In patients with episodic migraine (EM) and chronic migraine (CM), treatment with erenumab was associated with a significant and sustained reduction in the use of acute headache medication, and ...

A newly developed decision tool may help clinicians determine which patients presenting in the emergency department (ED) with headache require investigation for subarachnoid hemorrhage (SAH). A study ...

A recent meta-analysis looked at noninvasive vagus nerve stimulation (nVNS), a nonpharmacologic method of acute pain relief for headaches. A recent literature review about the use of noninvasive vagus ...

Fremanezumab, a humanized monoclonal antibody that selectively targets calcitonin gene–related peptide, is approved for the prevention of migraine in adults. Evidence from randomized, controlled ...

Anyone who's experienced the splitting pain of a bad headache or migraine attack knows how difficult it can be to work, drive, or even carry on a conversation while your head is pounding. But when a ...

Headache is the chief complaint in 2-3% of patients on admission to emergency departments (EDs) in the United States – the fourth most common reason for an ED visit. The incidence of headaches with ...

The American College of Physicians has provided a clinical guideline for migraine treatment, recommending the addition of triptan to NSAID or acetaminophen to treat moderate-to-severe acute episodic ...

Neurologist and headache specialist Dr Randolph Evans, of Baylor College of Medicine, reflects on his own personal history as a migraine sufferer and the prevalence of migraine among other ...

Please provide your email address to receive an email when new articles are posted on . The systematic review included 24 studies and 4,688 adults with hemorrhagic stroke. There were no significant ...